Lv2
130 积分 2025-01-03 加入
Personalized care for patients with EGFR‐mutant nonsmall cell lung cancer: Navigating early to advanced disease management
5分钟前
已完结
Unveiling the molecular and clinical risk landscape of second primary lung cancer in resected non-small cell lung cancer
19分钟前
求助中
Chinese expert consensus on perioperative management of patients with operable anaplastic lymphoma kinase-fusion positive non–small-cell lung cancer
24分钟前
已完结
Management of Patients with Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline
29分钟前
已完结
Prognostic implications of uncommon EGFR exon 19 deletion-insertion mutations in non-small cell lung cancer treated with third-generation EGFR-TKIs
1小时前
已完结
Case Report: Durable complete response to antigen-specific cytotoxic T lymphocyte therapy in advanced EGFR-TKI resistant lung adenocarcinoma: a case of adoptive cellular immunotherapy overcoming acquired targeted resistance
5天前
已完结
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial
6天前
已完结
The International Association for the Study of Lung Cancer Staging Project: The Impact of Common Molecular Alterations on Overall Survival in NSCLC in Initial Analyses of the IASLC Ninth Edition Staging Database
7天前
已完结
Translational analysis of NSD3 gene amplification in lung squamous cell carcinoma: Clinical and prognostic insights from histopathological analysis of patient samples
7天前
已完结
Prognostic impact and characteristics of ROS1 fusion in patients with surgically resected lung adenocarcinoma
7天前
已完结
皖公网安备34019202002308
